Neurol. pro Praxi, 2006; 4: 192-194

Psychiatrická problematika u sclerosis multiplex

Mgr. Jana Dušánková1, Eva Havrdová2
1 MS centrum, Neurologická klinika 1. LF UK a VFN, Praha
2 Centrum pro demyelinizační onemocnění Neurologická klinika 1. LF UK a VFN Praha

Roztroušená skleróza mozkomíšní (RS) je nejčastějším onemocněním CNS s autoimunitními patogenetickými mechanismy u mladých dospělých. Dlouhou dobu byl zájem odborníků soustředěn z velké části na neurologické příznaky, které RS způsobuje. Toto onemocnění je však doprovázeno celou řadou psychiatrických poruch postihujících oblast kognice, afektů i osobnosti. Tyto poruchy mohou být primární či sekundární povahy a mohou odrážet neurologické poškození nebo funkční stres spojený s chronickým, invalidizujícím onemocněním. Mnohdy zůstávají diagnosticky i terapeuticky nedoceněny, přestože zásadním způsobem mění kvalitu života pacientů s RS.

Keywords: roztroušená skleróza mozkomíšní, deprese, kognitivní porucha, neuropsychologické testy

Published: November 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dušánková J, Havrdová E. Psychiatrická problematika u sclerosis multiplex. Neurol. praxi. 2006;7(4):192-194.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benedict RHB, Fischer JS, Archibald CJ, Arnett PA et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16: 381-383. Go to original source... Go to PubMed...
    2. Benedict RHB, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi CW. Prediction of neuropsychological impairment in multiple sclerosis: a comparison of conventional MRI measures of atrophy and lesion burden. Arch Neurol 2004. Go to original source...
    3. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003; 16: 283-288. Go to original source... Go to PubMed...
    4. Demaree HA, De Luca J, Gandino EA, Diamond BJ. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation. J Neurol Neurosurg Psychiatry 1999; 67: 661-663. Go to original source... Go to PubMed...
    5. Diaz-Qlavarrieta C, Cummings JL, Velasquez I, Cadena CG. Neuropsychiatric manifestation of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999; 11: 51-57. Go to original source... Go to PubMed...
    6. Feinstein A, Ron M, Thompson A. A serial study of psychometric and magnetic resonance imagining changes in multiple sclerosis. Brain 1993; 116: 569-602. Go to original source... Go to PubMed...
    7. Fishman I, Benedict RHB, Bakshi CW, Priore R, Weinstock-Guttman B. Construct validity and prevalence of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2003. Go to original source... Go to PubMed...
    8. Havrdová E a kol. Neuroimunologie. Praha: Maxdorf 2004.
    9. Hornstein A, Seliger G, Flax J et al. Fluoxetin in treating emotional lability. Brain Inj 1993; 7(2): 189. Go to original source... Go to PubMed...
    10. Höschl C, Libiger J, Švestka J. Psychiatrie (2. doplněné a opravené vydání). Praha: Tigris 2004.
    11. Iannaconne S, Ferini-Strambi L. Pharmacological treatment of emotional lability. Clin Neuropharmacol 1996; 19: 532-535. Go to original source... Go to PubMed...
    12. Mendez MF. The neuropsychiatry of multiple sclerosis. Int J Psychiatry Med 1995; 25: 123-130. Go to original source... Go to PubMed...
    13. Minden SL. Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol; 6 (Suppl 2): 160-167.
    14. Nyehuis DL, Rao SM, Zajecka JM, Luchetta T et al. Mood disturbances versus other symptoms of depression in multiple sclerosis. J Int Neuropsychol Soc 1995; 1: 291-296. Go to original source... Go to PubMed...
    15. Patten SB, Metz LM. Depression in multiple sclerosis. Psychoter Psychosom 1999; 66: 286-292. Go to original source... Go to PubMed...
    16. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns and prediction. Neurology 1991; 41: 685-691. Go to original source... Go to PubMed...
    17. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning. Neurology 1991; 41: 692-696. Go to original source... Go to PubMed...
    18. Sadovnik AD, Remick RA, Allen J et al. Depression and multiple sclerosis. Neurology 1996; 46: 628-632. Go to original source... Go to PubMed...
    19. Stenager EN, Koch-Henriksen N, Stenager E. Risk factors for suicide in multiple sclerosis. Psychoter Psychosom 1996; 65: 86-90. Go to original source... Go to PubMed...
    20. Sullivan MJ, Weinshenker B, Mikail S, Edgley K. Depression before an after diagnosis of multiple sclerosis. Mult Scler 1995; 1: 104-108. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.